0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Nitinol-based Stent - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-12X8112
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global and China Nitinol based Stent Market Insights Forecast to 2027
BUY CHAPTERS

Nitinol-based Stent - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-12X8112
Report
October 2024
Pages:138
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Nitinol-based Stent - Market Size

The global market for Nitinol-based Stent was estimated to be worth US$ 12530 million in 2023 and is forecast to a readjusted size of US$ 20770 million by 2030 with a CAGR of 8.4% during the forecast period 2024-2030

Nitinol-based Stent - Market

Nitinol-based Stent - Market

Coronary stent is a tube-shaped device placed in the coronary arteries that supply blood to the heart, to keep the arteries open in the treatment of coronary heart disease.
The Nitinol-based Medical Device market is driven by the unique properties of nitinol, a shape memory alloy that exhibits excellent flexibility and elasticity. Nitinol's ability to revert to its original shape after deformation makes it a sought-after material for medical devices, such as stents, guidewires, and filters. The growing prevalence of cardiovascular diseases and the need for minimally invasive interventions contribute to market growth, as nitinol-based devices offer enhanced maneuverability and reduced patient trauma. Moreover, advancements in device design and fabrication techniques, coupled with the trend towards personalized medicine, further propel adoption. However, challenges include the complex manufacturing processes required for nitinol devices and addressing potential incompatibilities with other materials. Ensuring consistent device performance and optimizing deployment accuracy in intricate anatomies pose ongoing concerns. The market's success relies on continuous research to improve nitinol-based device designs, regulatory compliance, and collaborations between material scientists and medical device manufacturers to harness the unique properties of nitinol, offering innovative, safe, and effective solutions while navigating the evolving challenges of manufacturing intricacies and clinical applicability.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nitinol-based Stent, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Nitinol-based Stent by region & country, by Type, and by Application.
The Nitinol-based Stent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nitinol-based Stent.
Market Segmentation

Scope of Nitinol-based Stent - Market Report

Report Metric Details
Report Name Nitinol-based Stent - Market
Forecasted market size in 2030 US$ 20770 million
CAGR 8.4%
Forecasted years 2024 - 2030
Segment by Type:
  • Bare-metal Stent (BMS)
  • Drug-eluting Stent (DES)
Segment by Application
  • Hospital
  • Clinics
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Medtronic, Edwards Lifesciences, Abbott, Boston Scientific, TERUMO, C. R. Bard, Cordis, Cook Medical, B. Braun, Biotronik, Stryker, JOTEC, MicroPort, Acandis, ELLA-CS
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Nitinol-based Stent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Nitinol-based Stent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Nitinol-based Stent in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Nitinol-based Stent - Market size in 2030?

Ans: The Nitinol-based Stent - Market size in 2030 will be US$ 20770 million.

Who are the main players in the Nitinol-based Stent - Market report?

Ans: The main players in the Nitinol-based Stent - Market are Medtronic, Edwards Lifesciences, Abbott, Boston Scientific, TERUMO, C. R. Bard, Cordis, Cook Medical, B. Braun, Biotronik, Stryker, JOTEC, MicroPort, Acandis, ELLA-CS

What are the Application segmentation covered in the Nitinol-based Stent - Market report?

Ans: The Applications covered in the Nitinol-based Stent - Market report are Hospital, Clinics, Other

What are the Type segmentation covered in the Nitinol-based Stent - Market report?

Ans: The Types covered in the Nitinol-based Stent - Market report are Bare-metal Stent (BMS), Drug-eluting Stent (DES)

Recommended Reports

Nitinol Applications

Coronary & Vascular Stents

Other Medical Devices

1 Market Overview
1.1 Nitinol-based Stent Product Introduction
1.2 Global Nitinol-based Stent Market Size Forecast
1.2.1 Global Nitinol-based Stent Sales Value (2019-2030)
1.2.2 Global Nitinol-based Stent Sales Volume (2019-2030)
1.2.3 Global Nitinol-based Stent Sales Price (2019-2030)
1.3 Nitinol-based Stent Market Trends & Drivers
1.3.1 Nitinol-based Stent Industry Trends
1.3.2 Nitinol-based Stent Market Drivers & Opportunity
1.3.3 Nitinol-based Stent Market Challenges
1.3.4 Nitinol-based Stent Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Nitinol-based Stent Players Revenue Ranking (2023)
2.2 Global Nitinol-based Stent Revenue by Company (2019-2024)
2.3 Global Nitinol-based Stent Players Sales Volume Ranking (2023)
2.4 Global Nitinol-based Stent Sales Volume by Company Players (2019-2024)
2.5 Global Nitinol-based Stent Average Price by Company (2019-2024)
2.6 Key Manufacturers Nitinol-based Stent Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Nitinol-based Stent Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Nitinol-based Stent
2.9 Nitinol-based Stent Market Competitive Analysis
2.9.1 Nitinol-based Stent Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Nitinol-based Stent Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nitinol-based Stent as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Bare-metal Stent (BMS)
3.1.2 Drug-eluting Stent (DES)
3.2 Global Nitinol-based Stent Sales Value by Type
3.2.1 Global Nitinol-based Stent Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Nitinol-based Stent Sales Value, by Type (2019-2030)
3.2.3 Global Nitinol-based Stent Sales Value, by Type (%) (2019-2030)
3.3 Global Nitinol-based Stent Sales Volume by Type
3.3.1 Global Nitinol-based Stent Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Nitinol-based Stent Sales Volume, by Type (2019-2030)
3.3.3 Global Nitinol-based Stent Sales Volume, by Type (%) (2019-2030)
3.4 Global Nitinol-based Stent Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinics
4.1.3 Other
4.2 Global Nitinol-based Stent Sales Value by Application
4.2.1 Global Nitinol-based Stent Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Nitinol-based Stent Sales Value, by Application (2019-2030)
4.2.3 Global Nitinol-based Stent Sales Value, by Application (%) (2019-2030)
4.3 Global Nitinol-based Stent Sales Volume by Application
4.3.1 Global Nitinol-based Stent Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Nitinol-based Stent Sales Volume, by Application (2019-2030)
4.3.3 Global Nitinol-based Stent Sales Volume, by Application (%) (2019-2030)
4.4 Global Nitinol-based Stent Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Nitinol-based Stent Sales Value by Region
5.1.1 Global Nitinol-based Stent Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Nitinol-based Stent Sales Value by Region (2019-2024)
5.1.3 Global Nitinol-based Stent Sales Value by Region (2025-2030)
5.1.4 Global Nitinol-based Stent Sales Value by Region (%), (2019-2030)
5.2 Global Nitinol-based Stent Sales Volume by Region
5.2.1 Global Nitinol-based Stent Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Nitinol-based Stent Sales Volume by Region (2019-2024)
5.2.3 Global Nitinol-based Stent Sales Volume by Region (2025-2030)
5.2.4 Global Nitinol-based Stent Sales Volume by Region (%), (2019-2030)
5.3 Global Nitinol-based Stent Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Nitinol-based Stent Sales Value, 2019-2030
5.4.2 North America Nitinol-based Stent Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Nitinol-based Stent Sales Value, 2019-2030
5.5.2 Europe Nitinol-based Stent Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Nitinol-based Stent Sales Value, 2019-2030
5.6.2 Asia Pacific Nitinol-based Stent Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Nitinol-based Stent Sales Value, 2019-2030
5.7.2 South America Nitinol-based Stent Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Nitinol-based Stent Sales Value, 2019-2030
5.8.2 Middle East & Africa Nitinol-based Stent Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Nitinol-based Stent Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Nitinol-based Stent Sales Value
6.2.1 Key Countries/Regions Nitinol-based Stent Sales Value, 2019-2030
6.2.2 Key Countries/Regions Nitinol-based Stent Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Nitinol-based Stent Sales Value, 2019-2030
6.3.2 United States Nitinol-based Stent Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Nitinol-based Stent Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Nitinol-based Stent Sales Value, 2019-2030
6.4.2 Europe Nitinol-based Stent Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Nitinol-based Stent Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Nitinol-based Stent Sales Value, 2019-2030
6.5.2 China Nitinol-based Stent Sales Value by Type (%), 2023 VS 2030
6.5.3 China Nitinol-based Stent Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Nitinol-based Stent Sales Value, 2019-2030
6.6.2 Japan Nitinol-based Stent Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Nitinol-based Stent Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Nitinol-based Stent Sales Value, 2019-2030
6.7.2 South Korea Nitinol-based Stent Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Nitinol-based Stent Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Nitinol-based Stent Sales Value, 2019-2030
6.8.2 Southeast Asia Nitinol-based Stent Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Nitinol-based Stent Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Nitinol-based Stent Sales Value, 2019-2030
6.9.2 India Nitinol-based Stent Sales Value by Type (%), 2023 VS 2030
6.9.3 India Nitinol-based Stent Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Medtronic
7.1.1 Medtronic Company Information
7.1.2 Medtronic Introduction and Business Overview
7.1.3 Medtronic Nitinol-based Stent Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Medtronic Nitinol-based Stent Product Offerings
7.1.5 Medtronic Recent Development
7.2 Edwards Lifesciences
7.2.1 Edwards Lifesciences Company Information
7.2.2 Edwards Lifesciences Introduction and Business Overview
7.2.3 Edwards Lifesciences Nitinol-based Stent Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Edwards Lifesciences Nitinol-based Stent Product Offerings
7.2.5 Edwards Lifesciences Recent Development
7.3 Abbott
7.3.1 Abbott Company Information
7.3.2 Abbott Introduction and Business Overview
7.3.3 Abbott Nitinol-based Stent Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Abbott Nitinol-based Stent Product Offerings
7.3.5 Abbott Recent Development
7.4 Boston Scientific
7.4.1 Boston Scientific Company Information
7.4.2 Boston Scientific Introduction and Business Overview
7.4.3 Boston Scientific Nitinol-based Stent Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Boston Scientific Nitinol-based Stent Product Offerings
7.4.5 Boston Scientific Recent Development
7.5 TERUMO
7.5.1 TERUMO Company Information
7.5.2 TERUMO Introduction and Business Overview
7.5.3 TERUMO Nitinol-based Stent Sales, Revenue and Gross Margin (2019-2024)
7.5.4 TERUMO Nitinol-based Stent Product Offerings
7.5.5 TERUMO Recent Development
7.6 C. R. Bard
7.6.1 C. R. Bard Company Information
7.6.2 C. R. Bard Introduction and Business Overview
7.6.3 C. R. Bard Nitinol-based Stent Sales, Revenue and Gross Margin (2019-2024)
7.6.4 C. R. Bard Nitinol-based Stent Product Offerings
7.6.5 C. R. Bard Recent Development
7.7 Cordis
7.7.1 Cordis Company Information
7.7.2 Cordis Introduction and Business Overview
7.7.3 Cordis Nitinol-based Stent Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Cordis Nitinol-based Stent Product Offerings
7.7.5 Cordis Recent Development
7.8 Cook Medical
7.8.1 Cook Medical Company Information
7.8.2 Cook Medical Introduction and Business Overview
7.8.3 Cook Medical Nitinol-based Stent Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Cook Medical Nitinol-based Stent Product Offerings
7.8.5 Cook Medical Recent Development
7.9 B. Braun
7.9.1 B. Braun Company Information
7.9.2 B. Braun Introduction and Business Overview
7.9.3 B. Braun Nitinol-based Stent Sales, Revenue and Gross Margin (2019-2024)
7.9.4 B. Braun Nitinol-based Stent Product Offerings
7.9.5 B. Braun Recent Development
7.10 Biotronik
7.10.1 Biotronik Company Information
7.10.2 Biotronik Introduction and Business Overview
7.10.3 Biotronik Nitinol-based Stent Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Biotronik Nitinol-based Stent Product Offerings
7.10.5 Biotronik Recent Development
7.11 Stryker
7.11.1 Stryker Company Information
7.11.2 Stryker Introduction and Business Overview
7.11.3 Stryker Nitinol-based Stent Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Stryker Nitinol-based Stent Product Offerings
7.11.5 Stryker Recent Development
7.12 JOTEC
7.12.1 JOTEC Company Information
7.12.2 JOTEC Introduction and Business Overview
7.12.3 JOTEC Nitinol-based Stent Sales, Revenue and Gross Margin (2019-2024)
7.12.4 JOTEC Nitinol-based Stent Product Offerings
7.12.5 JOTEC Recent Development
7.13 MicroPort
7.13.1 MicroPort Company Information
7.13.2 MicroPort Introduction and Business Overview
7.13.3 MicroPort Nitinol-based Stent Sales, Revenue and Gross Margin (2019-2024)
7.13.4 MicroPort Nitinol-based Stent Product Offerings
7.13.5 MicroPort Recent Development
7.14 Acandis
7.14.1 Acandis Company Information
7.14.2 Acandis Introduction and Business Overview
7.14.3 Acandis Nitinol-based Stent Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Acandis Nitinol-based Stent Product Offerings
7.14.5 Acandis Recent Development
7.15 ELLA-CS
7.15.1 ELLA-CS Company Information
7.15.2 ELLA-CS Introduction and Business Overview
7.15.3 ELLA-CS Nitinol-based Stent Sales, Revenue and Gross Margin (2019-2024)
7.15.4 ELLA-CS Nitinol-based Stent Product Offerings
7.15.5 ELLA-CS Recent Development
8 Industry Chain Analysis
8.1 Nitinol-based Stent Industrial Chain
8.2 Nitinol-based Stent Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Nitinol-based Stent Sales Model
8.5.2 Sales Channel
8.5.3 Nitinol-based Stent Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Nitinol-based Stent Market Trends
    Table 2. Nitinol-based Stent Market Drivers & Opportunity
    Table 3. Nitinol-based Stent Market Challenges
    Table 4. Nitinol-based Stent Market Restraints
    Table 5. Global Nitinol-based Stent Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Nitinol-based Stent Revenue Market Share by Company (2019-2024)
    Table 7. Global Nitinol-based Stent Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Nitinol-based Stent Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Nitinol-based Stent Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Nitinol-based Stent Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Nitinol-based Stent Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Nitinol-based Stent
    Table 13. Global Nitinol-based Stent Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nitinol-based Stent as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Nitinol-based Stent Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Nitinol-based Stent Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Nitinol-based Stent Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Nitinol-based Stent Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Nitinol-based Stent Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Nitinol-based Stent Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Nitinol-based Stent Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Nitinol-based Stent Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Nitinol-based Stent Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Nitinol-based Stent Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Nitinol-based Stent Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Nitinol-based Stent Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Nitinol-based Stent Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Nitinol-based Stent Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Nitinol-based Stent Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Nitinol-based Stent Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Nitinol-based Stent Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Nitinol-based Stent Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Nitinol-based Stent Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Nitinol-based Stent Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Nitinol-based Stent Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Nitinol-based Stent Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Nitinol-based Stent Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Nitinol-based Stent Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Nitinol-based Stent Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Nitinol-based Stent Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Nitinol-based Stent Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Nitinol-based Stent Sales Value by Region (2019-2024) & (%)
    Table 44. Global Nitinol-based Stent Sales Value by Region (2025-2030) & (%)
    Table 45. Global Nitinol-based Stent Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Nitinol-based Stent Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Nitinol-based Stent Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Nitinol-based Stent Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Nitinol-based Stent Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Nitinol-based Stent Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Nitinol-based Stent Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Nitinol-based Stent Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Nitinol-based Stent Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Nitinol-based Stent Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Nitinol-based Stent Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Nitinol-based Stent Sales Volume, (2025-2030) & (K Units)
    Table 57. Medtronic Company Information
    Table 58. Medtronic Introduction and Business Overview
    Table 59. Medtronic Nitinol-based Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Medtronic Nitinol-based Stent Product Offerings
    Table 61. Medtronic Recent Development
    Table 62. Edwards Lifesciences Company Information
    Table 63. Edwards Lifesciences Introduction and Business Overview
    Table 64. Edwards Lifesciences Nitinol-based Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Edwards Lifesciences Nitinol-based Stent Product Offerings
    Table 66. Edwards Lifesciences Recent Development
    Table 67. Abbott Company Information
    Table 68. Abbott Introduction and Business Overview
    Table 69. Abbott Nitinol-based Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Abbott Nitinol-based Stent Product Offerings
    Table 71. Abbott Recent Development
    Table 72. Boston Scientific Company Information
    Table 73. Boston Scientific Introduction and Business Overview
    Table 74. Boston Scientific Nitinol-based Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Boston Scientific Nitinol-based Stent Product Offerings
    Table 76. Boston Scientific Recent Development
    Table 77. TERUMO Company Information
    Table 78. TERUMO Introduction and Business Overview
    Table 79. TERUMO Nitinol-based Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. TERUMO Nitinol-based Stent Product Offerings
    Table 81. TERUMO Recent Development
    Table 82. C. R. Bard Company Information
    Table 83. C. R. Bard Introduction and Business Overview
    Table 84. C. R. Bard Nitinol-based Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. C. R. Bard Nitinol-based Stent Product Offerings
    Table 86. C. R. Bard Recent Development
    Table 87. Cordis Company Information
    Table 88. Cordis Introduction and Business Overview
    Table 89. Cordis Nitinol-based Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Cordis Nitinol-based Stent Product Offerings
    Table 91. Cordis Recent Development
    Table 92. Cook Medical Company Information
    Table 93. Cook Medical Introduction and Business Overview
    Table 94. Cook Medical Nitinol-based Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Cook Medical Nitinol-based Stent Product Offerings
    Table 96. Cook Medical Recent Development
    Table 97. B. Braun Company Information
    Table 98. B. Braun Introduction and Business Overview
    Table 99. B. Braun Nitinol-based Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. B. Braun Nitinol-based Stent Product Offerings
    Table 101. B. Braun Recent Development
    Table 102. Biotronik Company Information
    Table 103. Biotronik Introduction and Business Overview
    Table 104. Biotronik Nitinol-based Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Biotronik Nitinol-based Stent Product Offerings
    Table 106. Biotronik Recent Development
    Table 107. Stryker Company Information
    Table 108. Stryker Introduction and Business Overview
    Table 109. Stryker Nitinol-based Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Stryker Nitinol-based Stent Product Offerings
    Table 111. Stryker Recent Development
    Table 112. JOTEC Company Information
    Table 113. JOTEC Introduction and Business Overview
    Table 114. JOTEC Nitinol-based Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. JOTEC Nitinol-based Stent Product Offerings
    Table 116. JOTEC Recent Development
    Table 117. MicroPort Company Information
    Table 118. MicroPort Introduction and Business Overview
    Table 119. MicroPort Nitinol-based Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. MicroPort Nitinol-based Stent Product Offerings
    Table 121. MicroPort Recent Development
    Table 122. Acandis Company Information
    Table 123. Acandis Introduction and Business Overview
    Table 124. Acandis Nitinol-based Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Acandis Nitinol-based Stent Product Offerings
    Table 126. Acandis Recent Development
    Table 127. ELLA-CS Company Information
    Table 128. ELLA-CS Introduction and Business Overview
    Table 129. ELLA-CS Nitinol-based Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. ELLA-CS Nitinol-based Stent Product Offerings
    Table 131. ELLA-CS Recent Development
    Table 132. Key Raw Materials Lists
    Table 133. Raw Materials Key Suppliers Lists
    Table 134. Nitinol-based Stent Downstream Customers
    Table 135. Nitinol-based Stent Distributors List
    Table 136. Research Programs/Design for This Report
    Table 137. Key Data Information from Secondary Sources
    Table 138. Key Data Information from Primary Sources
List of Figures
    Figure 1. Nitinol-based Stent Product Picture
    Figure 2. Global Nitinol-based Stent Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Nitinol-based Stent Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Nitinol-based Stent Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Nitinol-based Stent Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Nitinol-based Stent Report Years Considered
    Figure 7. Global Nitinol-based Stent Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Nitinol-based Stent Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Nitinol-based Stent Revenue in 2023
    Figure 10. Nitinol-based Stent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Bare-metal Stent (BMS) Picture
    Figure 12. Drug-eluting Stent (DES) Picture
    Figure 13. Global Nitinol-based Stent Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Nitinol-based Stent Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Nitinol-based Stent Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Nitinol-based Stent Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Nitinol-based Stent Price by Type (2019-2030) & (US$/Unit)
    Figure 18. Product Picture of Hospital
    Figure 19. Product Picture of Clinics
    Figure 20. Product Picture of Other
    Figure 21. Global Nitinol-based Stent Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Nitinol-based Stent Sales Value Market Share by Application, 2023 & 2030
    Figure 23. Global Nitinol-based Stent Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 24. Global Nitinol-based Stent Sales Volume Market Share by Application, 2023 & 2030
    Figure 25. Global Nitinol-based Stent Price by Application (2019-2030) & (US$/Unit)
    Figure 26. North America Nitinol-based Stent Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America Nitinol-based Stent Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe Nitinol-based Stent Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe Nitinol-based Stent Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific Nitinol-based Stent Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Nitinol-based Stent Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America Nitinol-based Stent Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America Nitinol-based Stent Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa Nitinol-based Stent Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa Nitinol-based Stent Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions Nitinol-based Stent Sales Value (%), (2019-2030)
    Figure 37. Key Countries/Regions Nitinol-based Stent Sales Volume (%), (2019-2030)
    Figure 38. United States Nitinol-based Stent Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States Nitinol-based Stent Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States Nitinol-based Stent Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe Nitinol-based Stent Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe Nitinol-based Stent Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe Nitinol-based Stent Sales Value by Application (%), 2023 VS 2030
    Figure 44. China Nitinol-based Stent Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China Nitinol-based Stent Sales Value by Type (%), 2023 VS 2030
    Figure 46. China Nitinol-based Stent Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan Nitinol-based Stent Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan Nitinol-based Stent Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan Nitinol-based Stent Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea Nitinol-based Stent Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea Nitinol-based Stent Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea Nitinol-based Stent Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia Nitinol-based Stent Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia Nitinol-based Stent Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia Nitinol-based Stent Sales Value by Application (%), 2023 VS 2030
    Figure 56. India Nitinol-based Stent Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India Nitinol-based Stent Sales Value by Type (%), 2023 VS 2030
    Figure 58. India Nitinol-based Stent Sales Value by Application (%), 2023 VS 2030
    Figure 59. Nitinol-based Stent Industrial Chain
    Figure 60. Nitinol-based Stent Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD